- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 26.06. | United Dogecoin erwirbt Mining-Flotte und strebt Betriebsaufnahme an | 15 | Investing.com Deutsch | ||
| SHUTTLE PHARMACEUTICALS Aktie jetzt für 0€ handeln | |||||
| 26.06. | United Dogecoin purchases mining fleet, targets operations start | 1 | Investing.com | ||
| 26.06. | Shuttle Pharmaceuticals Holdings Inc.: United Dogecoin Purchases Dogecoin Miners and Secures Renewable Energy Data Centre Site | 364 | Newsfile | Gaithersburg, Maryland--(Newsfile Corp. - June 26, 2026) - United Dogecoin Inc. ("United Dogecoin" or the "Company"), a Dogecoin mining company driven by industry experts recently acquired by Shuttle... ► Artikel lesen | |
| 25.06. | Shuttle Pharmaceuticals Holdings Inc.: United Dogecoin Advances Data Centre and Power Infrastructure Strategy to Support DOGE Mining and AI Hosting | 610 | Newsfile | Gaithersburg, Maryland--(Newsfile Corp. - June 25, 2026) - United Dogecoin Inc. ("United Dogecoin" or the "Company"), a Dogecoin mining and digital infrastructure company driven by industry experts... ► Artikel lesen | |
| 11.06. | Shuttle Pharmaceuticals Holdings, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
| 09.06. | Shuttle Pharmaceuticals Holdings Inc.: Shuttle Pharma Announces Reverse Stock Split will Become Effective on June 11, 2026, at 12:01 a.m., Eastern Time | 631 | Newsfile | Gaithersburg, Maryland--(Newsfile Corp. - June 9, 2026) - Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ: SHPH) ("Shuttle Pharma" or the "Company"), the owner of Molecule.ai, an artificial intelligence... ► Artikel lesen | |
| 27.05. | Shuttle Pharmaceuticals Holdings, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
| 14.05. | Shuttle Pharmaceuticals Holdings Inc.: Shuttle Pharmaceuticals and United Dogecoin Announce Purchase Order for up to 3,000 ElphaPex Dogecoin and Litecoin Mining Rigs | 726 | Newsfile | Gaithersburg, Maryland--(Newsfile Corp. - May 14, 2026) - Shuttle Pharmaceutical Holdings, Inc. (NASDAQ: SHPH) ("Shuttle" or the "Company") today announced the closing (the "Closing") of its previously... ► Artikel lesen | |
| 14.05. | Shuttle Pharma completes merger with United Dogecoin | 2 | Investing.com | ||
| 01.05. | Shuttle Pharmaceuticals Holdings Inc.: United Dogecoin Goes Public in Landmark Merger, Powering a Scaled, Next Generation DOGE Mining Operation | 856 | Newsfile | Gaithersburg, Maryland--(Newsfile Corp. - May 1, 2026) - Shuttle Pharmaceutical Holdings, Inc. (NASDAQ: SHPH) ("Shuttle") has entered into a definitive merger agreement to acquire United Dogecoin... ► Artikel lesen | |
| 01.05. | Shuttle Pharmaceuticals Holdings, Inc. - 8-K, Current Report | - | SEC Filings | ||
| 30.04. | Shuttle Pharmaceuticals Holdings Inc.: Shuttle Merges with United Dogecoin to Become the World's Largest Public Dogecoin Miner | 925 | Newsfile | Gaithersburg, Maryland--(Newsfile Corp. - April 30, 2026) - Shuttle Pharmaceutical Holdings, Inc. (NASDAQ: SHPH) ("Shuttle") has entered into a definitive merger agreement to acquire United Dogecoin... ► Artikel lesen | |
| 31.03. | Shuttle Pharmaceuticals Holdings, Inc. - 10-K, Annual Report | - | SEC Filings | ||
| 26.03. | Shuttle Pharma expands AI drug discovery platform capabilities | 4 | Investing.com | ||
| 26.03. | Shuttle Pharmaceuticals Holdings Inc.: Shuttle Pharmaceuticals Launches Autonomous Self Reasoning AI Agent for Scientific Workflows | 619 | Newsfile | Gaithersburg, Maryland--(Newsfile Corp. - March 26, 2026) - Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ: SHPH) ("Shuttle Pharma" or the "Company"), today announced a major advancement to its... ► Artikel lesen | |
| 12.03. | E.F. Hutton places $3.5M offering for Shuttle Pharmaceuticals | 1 | Investing.com | ||
| 12.03. | E.F. Hutton begleitet Kapitalerhöhung von Shuttle Pharmaceuticals über 3,5 Mio. US-Dollar | 1 | Investing.com Deutsch | ||
| 06.03. | Shuttle Pharmaceuticals announces $3.5 million public offering | 1 | Seeking Alpha | ||
| 06.03. | Shuttle Pharmaceuticals sichert sich 3,5 Mio. US-Dollar durch öffentliche Platzierung | 1 | Investing.com Deutsch | ||
| 06.03. | Shuttle Pharmaceuticals raises $3.5M in public offering | 2 | Investing.com |
1 2 Weiter >>
33 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| TILRAY BRANDS | 3,855 | -4,34 % | Tilray-Aktie: Startet jetzt die 700%-Chance? | Die Tilray-Aktie hat in den vergangenen Tagen eine bemerkenswerte Kehrtwende vollzogen. Nach enttäuschenden Quartalszahlen am 28. Juli geriet der Cannabis-Titel zunächst unter Druck, ehe bereits einen... ► Artikel lesen | |
| VIATRIS | 15,388 | +0,22 % | Weekly Buzz: Cipla, Viatris Win FDA Nod; Boston Scientific Cuts Jobs; argenx Snaps Up Forte Biosciences; Johnson & Johnson, GSK Strike Deals | NEW BRUNSWICK (dpa-AFX) - The healthcare sector delivered another eventful week, marked by major regulatory approvals, strategic partnerships, acquisitions, restructuring initiatives and significant... ► Artikel lesen | |
| SYNBIOTIC | 1,006 | +1,62 % | EQS-Adhoc: SYNBIOTIC SE: SOLIDMIND Group GmbH und Lean Labs Pharma GmbH beabsichtigen, Anträge auf Eröffnung von Insolvenzverfahren zu stellen | EQS-Ad-hoc: SYNBIOTIC SE / Schlagwort(e): Strategische Unternehmensentscheidung/Insolvenz
SYNBIOTIC SE: SOLIDMIND Group GmbH und Lean Labs Pharma GmbH beabsichtigen, Anträge auf Eröffnung... ► Artikel lesen | |
| TONIX PHARMACEUTICALS | 9,910 | +1,85 % | Tonix Pharmaceuticals Holding Corp.: Tonix Pharmaceuticals Announces Positive Minutes from Type C FDA Meeting to Discuss Adaptive Phase 2 Field Study of TNX-4800, a Human, anti-OspA Monoclonal Antibody, to Prevent Lyme Disease in the U.S. | ||
| SELLAS LIFE SCIENCES | 10,000 | -2,44 % | DesignRush: Brooke Sellas Joins DesignRush Podcast on Social Media's Revenue Risk | Miami, Florida--(Newsfile Corp. - June 23, 2026) - The latest episode of the DesignRush Podcast features Brooke Sellas, founder and CEO of B Squared Media. The episode explores why companies risk... ► Artikel lesen | |
| XORTX THERAPEUTICS | 1,814 | -5,20 % | XORTX Therapeutics Inc.: XORTX Announces Director Resignation | CALGARY, Alberta, July 31, 2026 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or the "Company") (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANU), a late-stage clinical pharmaceutical company focused... ► Artikel lesen | |
| SOLIGENIX | 0,384 | +1,72 % | SOLIGENIX, INC.: Soligenix Announces Recent Updates and First Quarter 2026 Financial Results | PRINCETON, N.J., May 8, 2026 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing... ► Artikel lesen | |
| TALPHERA | 1,160 | +2,65 % | Talphera, Inc.: Talphera Announces First Quarter 2026 Financial Results and Provides Corporate Update | NEPHRO CRRT clinical study expected to be completed this year
Cash and investments of $21.1 million at March 31, 2026
Conference call and webcast to be held on Wednesday... ► Artikel lesen | |
| SAVARA | 4,683 | -0,11 % | Savara Inc.: Savara Announces European and Australian Patent Offices Have Granted Patents for the Liquid Formulation of MOLBREEVI*, Providing Protection in Europe and Australia Until March 2041 | -- In December 2025, Savara and PARI Were Granted a Joint European Patent Covering the Investigational Drug-Device Combination of MOLBREEVI, Delivered Via PARI's Proprietary eFlow Nebulizer System... ► Artikel lesen | |
| SCYNEXIS | 5,160 | -4,44 % | Brookline bestätigt Kursziel für Scynexis von 44,64 USD und sieht massives Aufwärtspotenzial | ||
| THERIVA BIOLOGICS | 0,225 | 0,00 % | Theriva Biologics, Inc. - 8-K, Current Report | ||
| WAVE LIFE SCIENCES | 4,960 | -4,62 % | Wave Life Sciences Ltd.: Wave Life Sciences Reports Second Quarter 2026 Financial Results and Provides Business Update | Dosing underway in Phase 2a multidose portion of the INLIGHTTM trial of WVE-007 (INHBE GalNAc-siRNA) in individuals with obesity (BMI: 35-50 kg/m2) and comorbidities; trial will also inform WVE-007's... ► Artikel lesen | |
| TUHURA BIOSCIENCES | 1,870 | +3,31 % | TuHURA Biosciences, Inc./NV - 8-K, Current Report | ||
| THERAPEUTICSMD | 1,700 | -1,73 % | TherapeuticsMD, Inc. - 8-K, Current Report | ||
| YARROW BIOSCIENCE | 38,430 | +1,25 % | RTW Biotech Opp. - Yarrow Bioscience merges with VYNE Therapeutics |
Das Unternehmen SHUTTLE PHARMACEUTICALS HOLDINGS INC kann der Branche Pharma zugeordnet werden. Die relative Kursveränderung beträgt aktuell +20,55 % bei einem Aktienkurs von 4,400 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu SHUTTLE PHARMACEUTICALS HOLDINGS INC finden Sie auf Wallstreet Online.